You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2025

AbstractFullPdf
Nov 2021979729
Dec 2021413415223
Jan 202224624893
Feb 202211011052
Mar 202212513570
Apr 202218919354
May 202218719953
Jun 202212913634
Jul 2022929315
Aug 202212913238
Sep 202211211543
Oct 202212612840
Nov 2022636322
Dec 2022717118
Jan 2023545427
Feb 2023979929
Mar 2023656720
Apr 2023474730
May 2023484813
Jun 2023595918
Jul 2023767617
Aug 2023626214
Sep 2023414112
Oct 2023484820
Nov 2023565616
Dec 2023555621
Jan 2024363610
Feb 2024505017
Mar 2024454539
Apr 2024333323
May 2024333317
Jun 2024484814
Jul 2024505121
Aug 2024373616
Sep 2024262616
Oct 2024454524
Nov 2024242611
Dec 2024424517
Jan 2025545425
Feb 202513413423
Mar 2025393915
Apr 2025727242
May 2025434383
Jun 2025333613
Jul 2025220
Sep 2025110
Total364437031447